BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37929412)

  • 1. Extensive arm skin necrosis following administration of unfractionated heparin.
    Firouzabadi D; Petramfar P; Mahmoudi L
    Indian J Pharmacol; 2023; 55(5):332-334. PubMed ID: 37929412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Patient who developed heparin-induced thrombocytopenia type II after 24 years on hemodialysis].
    Gavranić BB; Basić-Jukić N; Kes P
    Acta Med Croatica; 2012 Oct; 66 Suppl 2():68-71. PubMed ID: 23513420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of heparin-induced thrombocytopenia.
    Keeling D; Davidson S; Watson H;
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia complicated by warfarin-induced skin necrosis.
    Howard-Thompson A; Usery JB; Lobo BL; Finch CK
    Am J Health Syst Pharm; 2008 Jun; 65(12):1144-7. PubMed ID: 18541684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widespread skin necrosis associated with unfractionated heparin therapy in a patient under chronic coumarin anticoagulation.
    Sanchez-Politta S; Angelillo-Scherrer A; Masouyé I; Borradori L
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):327-30. PubMed ID: 16503898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.
    Burger CF; Schlesinger JJ
    Ann Pharmacother; 2014 Feb; 48(2):286-91. PubMed ID: 24259642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous Immune Globulin (IVIG) for Treatment of Autoimmune Heparin-Induced Thrombocytopenia: A Systematic Review.
    Dougherty JA; Yarsley RL
    Ann Pharmacother; 2021 Feb; 55(2):198-215. PubMed ID: 32693627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of heparin-induced thrombocytopenia with rivaroxaban. Case report].
    Rivera O G; Corsi S O; Pavlovic J A; Aizman S A; Varas A P
    Rev Med Chil; 2017 Sep; 145(9):1213-1217. PubMed ID: 29424412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-induced thrombocytopenia and warfarin-induced skin necrosis: case report.
    Kaiber FL; Malucelli TO; Baroni Edo R; Schafranski MD; Akamatsu HT; Schmidt CC
    An Bras Dermatol; 2010; 85(6):915-8. PubMed ID: 21308322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No difference in risk for thrombocytopenia during treatment of pulmonary embolism and deep venous thrombosis with either low-molecular-weight heparin or unfractionated heparin: a metaanalysis.
    Morris TA; Castrejon S; Devendra G; Gamst AC
    Chest; 2007 Oct; 132(4):1131-9. PubMed ID: 17646239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivaroxaban for treatment of suspected or confirmed heparin-induced thrombocytopenia study.
    Linkins LA; Warkentin TE; Pai M; Shivakumar S; Manji RA; Wells PS; Wu C; Nazi I; Crowther MA
    J Thromb Haemost; 2016 Jun; 14(6):1206-10. PubMed ID: 27061271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of enoxaparin in patients with heparin-induced thrombocytopenia syndrome.
    Slocum MM; Adams JG; Teel R; Spadone DP; Silver D
    J Vasc Surg; 1996 May; 23(5):839-43. PubMed ID: 8667505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct-acting oral anticoagulants as emerging treatment options for heparin-induced thrombocytopenia.
    Miyares MA; Davis KA
    Ann Pharmacother; 2015 Jun; 49(6):735-9. PubMed ID: 25855702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant-induced skin necrosis in a patient with hereditary deficiency of protein S.
    Gailani D; Reese EP
    Am J Hematol; 1999 Mar; 60(3):231-6. PubMed ID: 10072117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Two surgical case reports showing atypical heparin-induced thrombocytopenia].
    Höhnke C; Haas S
    Chirurg; 2007 Feb; 78(2):138, 140-1. PubMed ID: 17252251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Warkentin TE; Greinacher A; Koster A; Lincoff AM
    Chest; 2008 Jun; 133(6 Suppl):340S-380S. PubMed ID: 18574270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A challenging case of heparin-induced skin necrosis without thrombocytopenia.
    Chidharla A; Rapoport EA; Naffakh N; Roberts JC
    Blood Coagul Fibrinolysis; 2022 Mar; 33(2):134-137. PubMed ID: 35140192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rivaroxaban as an Alternative Agent for Heparin-Induced Thrombocytopenia.
    Farasatinasab M; Zarei B; Moghtadaei M; Nasiripour S; Ansarinejad N; Zarei M
    J Clin Pharmacol; 2020 Oct; 60(10):1362-1366. PubMed ID: 32519800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical observation of heparin-induced thrombocytopenia].
    Tian HY; Meng Y; Zhang JB; Ma Q; Cheng GS; Fan FL; Wang J; Wan HM
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1405-7. PubMed ID: 19671335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enoxaparin-associated dermal necrosis: a consequence of cross-reactivity with heparin-mediated antibodies.
    Tonn ME; Schaiff RA; Kollef MH
    Ann Pharmacother; 1997 Mar; 31(3):323-6. PubMed ID: 9066940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.